Melatonin prevents nitric oxide-induced apoptosis by increasing the interaction between 14-3-3β and p-Bad in SK-N-MC cells

Journal of Pineal Research

Volumn 44, Issue 1, 2008, Pages 95-100

  Choi, Seung Il ^a   Joo, Seong Soo ^b   Yoo, Yeong Min ^c  

^a Yonsei University College of Medicine   (South Korea)

^b Chungbuk National University   (South Korea)

^c Sangji University   (South Korea)

Author keywords

14 3 3 ; Akt PKB; Bad; GSK3 ; Melatonin; SK N MC; SNAP

Indexed keywords

CYTOCHROME C; GLYCOGEN SYNTHASE KINASE 3ALPHA; GLYCOGEN SYNTHASE KINASE 3BETA; MELATONIN; N ACETYL S NITROSOPENICILLAMINE; NITRIC OXIDE; PROTEIN 14 3 3; PROTEIN 14 3 3BETA; PROTEIN BAD; PROTEIN BAX; PROTEIN BCL 2; PROTEIN KINASE B; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL PROTECTION; CONTROLLED STUDY; CYTOSOL; ENZYME PHOSPHORYLATION; ENZYME RELEASE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; NEUROBLASTOMA CELL; PINEAL BODY; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION;

14-3-3 PROTEINS; APOPTOSIS; BCL-ASSOCIATED DEATH PROTEIN; CELL LINE, TUMOR; HUMANS; MELATONIN; NITRIC OXIDE; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION;

EID: 36849029149     PISSN: 07423098     EISSN: 1600079X     Source Type: Journal    
DOI: 10.1111/j.1600-079X.2007.00494.x     Document Type: Article

References (42)

1. Karasek M, Winczyk K. Melatonin in humans. J Physiol Pharmacol 2006 57 : 19 39.
2. Allegra M, Reiter RJ, Tan DX et al. The chemistry of melatonin's interaction with reactive species. J Pineal Res 2003 34 : 1 10.
3. Rodriguez C, Mayo JC, Sainz RA et al. Regulation of antioxidant enzymes: a significant role for melatonin. J Pineal Res 2004 36 : 1 9.
4. Sun FY, Lin X, Mao LZ et al. Neuroprotection by melatonin against ischemic neuronal injury associated with modulation of DNA damage and repair in the rat following a transient cerebral ischemia. J Pineal Res 2002 33 : 48 56.
5. Yoo YM, Yim SV, Kim SS et al. Melatonin suppresses NO-induced apoptosis via induction of Bcl-2 expression in PGT-β immortalized pineal cells. J Pineal Res 2002 33 : 146 150.
6. Jou MJ, Peng TI, Reiter RJ et al. Visualization of the antioxidative effects of melatonin at the mitochondrial level during oxidative stress-induced apoptosis of rat brain astrocytes. J Pineal Res 2004 37 : 55 70.
7. Nava M, Romero F, Quiroz Y et al. Melatonin attenuates acute renal failure and oxidative stress induced by mercuric chloride in rats. Am J Physiol 2000 279 : F910 F918.
8. Siu AW, Maldonado M, Sanchez-Hidalgo M et al. Protective effects of melatonin in experimental free radical-related ocular diseases. J Pineal Res 2006 40 : 101 109.
9. Wu YH, Feenstra MG, Zhou JN et al. Molecular changes underlying reduced pineal melatonin levels in Alzheimer disease: alterations in preclinical and clinical stages. J Clin Endocrinol Metab 2003 88 : 5898 5906.
10. Ferrari E, Arcaini A, Gornati R et al. Pineal and pituitary- adrenocortical function in physiological aging and in senile dementia. Exp Gerontol 2000 35 : 1239 1250.
11. Ohashi Y, Okamoto N, Uchida K et al. Daily rhythm of serum melatonin levels and effect of light exposure in patients with dementia of the Alzheimer's type. Biol Psychiatry 1999 45 : 1646 1652.
12. Liu RY, Zhou JN, van Heerikhuize J et al. Decreased melatonin levels in postmortem cerebrospinal fluid in relation to aging, Alzheimer's disease, and apolipoprotein Eepsilon4/4 genotype. J Clin Endocrinol Metab 1999 84 : 323 327.
13. Zhou JN, Liu RY, Kamphorst W et al. Early neuropathological Alzheimer's changes in aged individuals are accompanied by decreased cerebrospinal fluid melatonin levels. J Pineal Res 2003 35 : 125 130.
14. Manev H, Uz T, Kharlamov A et al. Increased brain damage after stroke or excitotoxic seizures in melatonin-deficient rats. FASEB J 1996 10 : 1546 1551.
15. Guerrero JM, Reiter RJ, Ortiz GG et al. Melatonin prevents increases in neural nitric oxide and cyclic GMP production after transient brain ischemia and reperfusion in the Mongolian gerbil (Meriones unguiculatus). J Pineal Res 1997 23 : 24 31.
16. Ushio-Fukai M, Alexander RW, Akers M et al. Reactive oxygen species mediate the activation of Akt/protein kinase B by angiotensin II in vascular smooth muscle cells. J Biol Chem 1999 274 : 22699 22704.
17. Anhe GF, Caperuto LC, Pereira-Da-Silva M et al. In vivo activation of insulin receptor tyrosine kinase by melatonin in the rat hypothalamus. J Neurochem 2004 90 : 559 566.
18. Henshall DC, Araki T, Schindler CK et al. Activation of Bcl-2-associated death protein and counter-response of Akt within cell populations during seizure-induced neuronal death. J Neurosci 2002 22 : 8458 8465.
19. Kim AH, Yano H, Cho H et al. Akt1 regulates a JNK scaffold during excitotoxic apoptosis. Neuron 2002 35 : 697 709.
20. Figueroa S, Canadas S, Arce C et al. SNAP, a NO donor, induces cortical neuron death by a mechanism in which the caspase pathway is implicated. Brain Res 2005 1047 : 168 176.
21. Oyadomari S, Takeda K, Takiguchi M et al. Nitric oxide-induced apoptosis in pancreatic beta cells is mediated by the endoplasmic reticulum stress pathway. Proc Natl Acad Sci USA 2001 98 : 10845 10850.
22. Saed GM, Abu-Soud HM, Diamond MP. Role of nitric oxide in apoptosis of human peritoneal and adhesion fibroblasts after hypoxia. Fertil Steril 2004 82 : 1198 1205.
23. Storling J, Binzer J, Andersson AK et al. Nitric oxide contributes to cytokine-induced apoptosis in pancreatic beta cells via potentiation of JNK activity and inhibition of Akt. Diabetologia 2005 48 : 2039 2050.
24. Wei T, Chen C, Hou J et al. Nitric oxide induces oxidative stress and apoptosis in neuronal cells. Biochim Biophys Acta 2000 1498 : 72 79.
25. Lawlor MA, Alessi DR. PKB/Akt: a key mediator of cell proliferation, survival and insulin responses? J Cell Sci 2001 114 : 2903 2910.
26. Brazil DP, Yang ZZ, Hemmings BA. Advances in protein kinase B signalling: AKTion on multiple fronts. Trends Biochem Sci 2004 29 : 233 242.
27. Chen XQ, Fung YW, Yu AC. Association of 14-3-3 gamma and phosphorylated Bad attenuates injury in ischemic astrocytes. J Cereb Blood Flow Metab 2005 25 : 338 347.
28. Chang HM, Ling EA, Chen CF et al. Melatonin attenuates the neuronal NADPH-d/NOS expression in the nodose ganglion of acute hypoxic rats. J Pineal Res 2002 32 : 65 73.
29. Lee SH, Chun W, Kong PJ et al. Sustained activation of Akt by melatonin contributes to the protection against kainic acid-induced neuronal death in hippocampus. J Pineal Res 2006 40 : 79 85.
30. Masters SC, Yang H, Datta SR et al. 14-3-3 inhibits Bad-induced cell death through interaction with serine-136. Mol Pharmacol 2001 60 : 1325 1331.
31. Eckert A, Keil U, Marques CA et al. Mitochondrial dysfunction, apoptosis, and Alzheimer's disease. Biochem Pharmacol 2003 66 : 1627 1634.
32. Schapira AH. Mitochondrial dysfunction in neurodegenerative disorders. Biochim Biophys Acta 1998 1366 : 225 233.
33. Choi SI, Ju WK, Choi EK et al. Mitochondrial dysfunction induced by oxidative stress in the brains of hamsters infected with the 263 K scrapie agent. Acta Neuropathol (Berl) 1998 96 : 279 286.
34. Janciauskiene S, Wright HT, Lindgren S. Fibrillar Alzheimer's amyloid peptide Aβ(1-42) stimulates low density lipoprotein binding and cell association, free radical production and cell cytotoxicity in PC12 cells. Neuropeptides 1999 33 : 510 516.
35. Law A, Gauthier S, Quirion R. Neuroprotective and neurorescuing effects of isoform-specific nitric oxide synthase inhibitors, nitric oxide scavenger, and antioxidant against β-amyloid toxicity. Br J Pharmacol 2001 133 : 1114 1124.
36. Vodovotz Y, Lucia MS, Flanders KC et al. Inducible nitric oxide synthase in tangle-bearing neurons of patients with Alzheimer's disease. J Exp Med 1996 184 : 1425 1433.
37. Ju WK, Park KJ, Choi EK et al. Expression of inducible nitric oxide synthase in the brains of scrapie-infected mice. J Neurovirol 1998 4 : 445 450.
38. Pappolla MA, Chyan YJ, Poeggeler B et al. An assessment of the antioxidant and the antiamyloidogenic properties of melatonin: implications for Alzheimer's disease. J Neural Transm 2000 107 : 203 231.
39. Feng Z, Chang Y, Cheng Y, Zhang BL. Melatonin alleviates behavioral deficits associated with apoptosis and cholinergic system dysfunction in the APP 695 transgenic mouse model of Alzheimer's disease. J Pineal Res 2004 37 : 129 136.
40. Poeggeler B, Miravalle L, Zagorski MG et al. Melatonin reverses the profibrillogenic activity of apolipoprotein E4 on the Alzheimer amyloid A beta peptide. Biochemistry 2001 40 : 14995 15001.
41. Pappolla M, Bozner P, Soto C et al. Inhibition of Alzheimer β-fibrillogenesis by melatonin. J Biol Chem 1998 273 : 7185 7188.
42. Wang JZ, Wang ZF. Role of melatonin in Alzheimer-like neurodegeneration. Acta Pharmacol Sin 2006 27 : 41 49.